ReviewFrontiers in pharmacology2018
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases.
Heng Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
265 papers cite itlatest 60 shown
this paperpooled ittrialcites it